Shelby’s ruling means Dressen’s case will move forward.
Dressen wrote on the social media platform X that the judge “handed down a thoughtful and timely decision.”
“My deepest gratitude to the court for respectfully reviewing this important case and allowing it to move forward,” she said.
An AstraZeneca spokesperson told The Epoch Times in an email that the company cannot comment on ongoing litigation.
“Patient safety is our highest priority,” the spokesperson said. “From the body of evidence in clinical trials and real-world data, the AstraZeneca-Oxford vaccine has continuously been shown to have an acceptable safety profile and regulators around the world consistently state that the benefits of vaccination outweigh the risks of extremely rare potential side effects.”